Close

Production & Manufacturing

Triple-Combination pMDIs Expanding Complex Inhalation Drug Delivery

The management of complex respiratory conditions, such as chronic obstructive pulmonary disease and severe asthma, has undergone a significant transformation with the introduction of triple-combination therapies. By combining an inhaled corticosteroid, a long-acting beta2-agonist, and a long-acting muscarinic antagonist...

Integrated Dose Counters Improving pMDI Dose Tracking

The pharmaceutical industry has long recognized that the efficacy of respiratory treatments is heavily dependent on patient adherence. One of the most significant challenges in the use of pressurized metered-dose inhalers is the inability of users to determine the...

Drug-Device Co-Development Improving Inhalation Product Scale-Up

The complexity of delivering active pharmaceutical ingredients to the lungs requires a level of precision that transcends traditional oral dosage manufacturing. Achieving successful inhalation product scale-up depends on the early integration of formulation characteristics with device mechanics. When pharmaceutical...

Onyx Scientific Boosts API Manufacturing Capacity in UK

Onyx Scientific, a global small molecule CDMO, is investing more than ยฃ1.5m to expand its Good Manufacturing Practice (GMP) facilities and increase commercial active pharmaceutical ingredient (API) production at its Sunderland UK facility. The expansion will add four GMP...

Neuland Expands Peptide Manufacturing Capacity in India

Neuland Laboratories is accelerating its peptide manufacturing expansion, with the first of four planned modules now operational at its commercial peptide manufacturing site in Hyderabad. The company said the newly commissioned module is designed to meet growing customer demand...

Upstream Process Optimization for Biologics Production Efficiency

The efficiency of biologics production is fundamentally determined at the start of the development cycle during cell line selection. Chinese Hamster Ovary cells remain the industry standard due to their ability to perform human-like post-translational modifications, which are essential...

mRNA Manufacturing Platforms for Advanced Therapy Scalability

The rapid development of messenger RNA technology has necessitated a shift in how the pharmaceutical sector approaches the production of advanced therapies. Unlike traditional biologics that rely on complex cell culture systems, mRNA manufacturing platforms utilize cell-free enzymatic synthesis,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป